Your browser doesn't support javascript.
loading
Monitoring of SARS-CoV-2 seroprevalence among primary healthcare patients in the Barcelona Metropolitan Area: the SeroCAP sentinel network protocol.
Sentís, Alexis; Torán, Pere; Esperalba, Juliana; Agustí, Cristina; Ángel, Miguel; Fernández, Munoz Gema; Dopico, Eva; Salvador-González, Betlem; González, Maria Victoria; Bordas, Anna; Antón, Andrés; Violan, Concepció; Montoro-Fernández, Marcos; Aceiton, Jordi; Egea-Cortés, Laia; Alonso, Lucía; Dacosta-Aguayo, Rosalia; Calatayud, Laura; Lejardi, Yolanda; Mendioroz, Jacobo; Basora, Josep; Reyes-Urueña, Juliana; Casabona, Jordi.
Afiliação
  • Sentís A; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Torán P; Instituto de Salud Carlos III, Madrid, Spain.
  • Esperalba J; Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol, Barcelona, Spain.
  • Agustí C; Departament de Medicina, Universitat de Girona, Girona, Spain.
  • Ángel M; Department of Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Fernández MG; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain cagusti@iconcologia.net.
  • Dopico E; Instituto de Salud Carlos III, Madrid, Spain.
  • Salvador-González B; Gerència Territorial de Barcelona, Institut Català de la Salut, Barcelona, Spain.
  • González MV; IDIAP Jordi Gol, Barcelona, Spain.
  • Bordas A; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Antón A; Microbiology Department, Laboratori Clínic Territorial Metropolitana Sud, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
  • Violan C; Unitat de Suport a la Recerca Costa de Ponent, Direcció Atenció Primària Costa de Ponent, Gerència Territorial Metropolitana Sud, Institut Català de la Salut, Barcelona, Spain.
  • Montoro-Fernández M; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Aceiton J; Instituto de Salud Carlos III, Madrid, Spain.
  • Egea-Cortés L; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Alonso L; Microbiology Department, Hospital Vall d'Hebron, Barcelona, Spain.
  • Dacosta-Aguayo R; Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol, Mataró, Spain.
  • Calatayud L; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Lejardi Y; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Mendioroz J; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Basora J; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Reyes-Urueña J; Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol, Mataró, Spain.
  • Casabona J; Microbiology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
BMJ Open ; 12(2): e053237, 2022 02 09.
Article em En | MEDLINE | ID: mdl-35140153

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha